TY - JOUR
T1 - A Randomized Trial of PHOTOdynamic Surgery in Non-Muscle-Invasive Bladder Cancer
AU - Heer, Rakesh
AU - Lewis, Rebecca
AU - Vadiveloo, Thenmalar
AU - Yu, Ge
AU - Mariappan, Paramananthan
AU - Cresswell, Joanne
AU - McGrath, John
AU - Nabi, Ghulam
AU - Mostafid, Hugh
AU - Lazarowicz, Henry
AU - Kelly, John
AU - Duncan, Anne
AU - Penegar, Steven
AU - Breckons, Matt
AU - Wilson, Laura
AU - Clark, Emma
AU - Feber, Andy
AU - Orozco-Leal, Giovany
AU - Tandogdu, Zafer
AU - Taylor, Ernest
AU - N'Dow, James
AU - Norrie, John
AU - Ramsay, Craig
AU - Rice, Stephen
AU - Vale, Luke
AU - MacLennan, Graeme
AU - Hall, Emma
PY - 2022/9/2
Y1 - 2022/9/2
N2 - PDD or WL Resection of Tumors in NMIBCIn this open-label trial, patients with intermediate- or high-risk non-muscle-invasive bladder cancer at diagnosis were randomly assigned to photodynamic diagnosis or white light-guided transurethral resection of bladder tumor. Three-year recurrence-free rates were 57.8% and 61.6% in the PDD and WL groups, respectively, with no difference in quality-adjusted life years between the treatment groups at 3 years.
AB - PDD or WL Resection of Tumors in NMIBCIn this open-label trial, patients with intermediate- or high-risk non-muscle-invasive bladder cancer at diagnosis were randomly assigned to photodynamic diagnosis or white light-guided transurethral resection of bladder tumor. Three-year recurrence-free rates were 57.8% and 61.6% in the PDD and WL groups, respectively, with no difference in quality-adjusted life years between the treatment groups at 3 years.
KW - Humans
KW - Photosensitizing Agents
KW - Aminolevulinic Acid
KW - Non-Muscle Invasive Bladder Neoplasms
KW - Urinary Bladder Neoplasms/diagnosis
KW - Urologic Surgical Procedures
U2 - 10.1056/EVIDoa2200092
DO - 10.1056/EVIDoa2200092
M3 - Article
C2 - 38319866
SN - 2766-5526
VL - 1
JO - NEJM evidence
JF - NEJM evidence
IS - 10
M1 - EVIDoa2200092
ER -